<a href="https://laohu8.com/S/NVO">Novo Nordisk</a> wins US approval for weight-loss pillDec 22 (Reuters) - The U.S. Food and Drug Administration approved Novo Nordisk's NOVOb.CO weight-loss pill on Monday, giving the Danish drugmaker a leg up in the race to market a potent oral medication for shedding pounds as it looks to regain lost ground from rival Eli Lilly LLY.N.
(Reporting by Maggie Fick, Patrick Wingrove, Mariam Sunny and Mrinalika Roy in Bengaluru; Editing by Adam Jourdan and Bill Berkrot)
((Mariam.ESunny@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments